We investigated the safety and effectiveness of percutaneous release for de Quervain's disease using Sono-Instruments® in cadaveric specimens. The mean procedure duration was 4 minutes, and complete release was achieved in all specimens.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/17531934251313988 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
De Quervain's Tenosynovitis Virally Exacerbated by SARS-CoV-2 and Influenza Infections: A Case Report.
Case Rep Infect Dis
January 2025
Division of Pediatric Infectious Diseases, Virginia Commonwealth University Health System, Richmond, Virginia, USA.
We present the case of a fully vaccinated 39-year-old male with no pertinent past medical history who initially presented with De Quervain's tenosynovitis which was successfully treated with a corticosteroid injection. His symptoms recurred during a COVID-19 infection, which was treated with a repeat corticosteroid injection. Symptoms recurred during an influenza infection and were subsequently treated with a first dorsal compartment release.
View Article and Find Full Text PDFDe Quervain's disease: Ultrasound-guided release.
Hand Surg Rehabil
January 2025
Orthopedic Surgery Department, CHU Caremeauux,Debré, Nîmes, France.
Purpose: This study aimed to evaluate the outcomes of a novel antegrade, ultrasound-guided release of the first extensor tendon compartment for treating De Quervain's disease.
Methods: We conducted a retrospective, single-center study of 34 patients who underwent ultrasound-guided release of the first extensor compartment for clinically diagnosed De Quervain's disease between June 2022 and December 2023. Inclusion criteria included age >18 years and failure of conservative treatment (e.
Percutaneous treatment of de Quervain's disease using Sono-Instruments®: A feasibility study.
J Hand Surg Eur Vol
January 2025
Laboratory of Anatomy, Biomechanics and Organogenesis, Faculty of Medicine, Université Libre de Bruxelles ULB, Brussels, Belgium.
We investigated the safety and effectiveness of percutaneous release for de Quervain's disease using Sono-Instruments® in cadaveric specimens. The mean procedure duration was 4 minutes, and complete release was achieved in all specimens.
View Article and Find Full Text PDFEffects of high-intensity laser therapy in patients with De Quervain's tenosynovitis: A systematic review and meta-analysis.
J Hand Ther
January 2025
Physiotherapeutic Resources Research Laboratory, Department of Physical Therapy, Federal University of São Carlos (UFSCar), São Paulo, Brazil; Department of Rehabilitation Sciences, University of Hartford, West Hartford, CT, USA.
Background: De Quervain's tenosynovitis (QT) is common among individuals performing repetitive manual tasks and significantly affects daily activities due to pain. While traditional treatments often provide limited relief, high-intensity laser therapy (HILT) shows as a potential analgesic resource.
Purpose: This systematic review aimed to evaluate the analgesic effects of HILT in patients with QT.
ASSESSMENT OF SATISFACTION IN PATIENTS UNDERGOING SURGICAL TREATMENT BY THE WALANT TECHNIQUE.
Acta Ortop Bras
January 2025
Santa Casa de Misericórdia de Sao Paulo, Pavilhão "Fernandinho Simonsen", Especialização em Mao e Microcirurgia, Sao Paulo, SP, Brazil.
Objective: To analyze the satisfaction of patients who underwent hand surgical treatment with the wide-awake local anesthesia no tourniquet (WALANT) anesthesia technique.
Methods: This is a cross-sectional study on the satisfaction of patients who underwent hand surgical treatment with the WALANT technique. These patients were treated at the Hand and Microsurgery outpatient clinic of a public hospital from March 2020 to March 2022.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!